Final Analysis of Second-Line Axicabtagene Ciloleucel for Large B-Cell Lymphoma Patients Not Eligible for Transplantation: ALYCANTE Study Results
-
By
-
Roch Houot
-
Jean Lemoine
-
Alexis Claudel
-
Emmanuel Bachy
-
Guillaume Cartron
-
François-Xavier Gros
-
Franck Morschhauser
-
Lucie Oberic
-
Thomas Gastinne
-
Pierre Feugier
-
Rémy Duléry
-
Catherine Thieblemont
-
Magalie Joris
-
Fabrice Jardin
-
Sylvain Choquet
-
Olivier Casasnovas
-
Gabriel Brisou
-
Morgane Cheminant
-
Jacques-Olivier Bay
-
Jules Coville
-
Francisco Llamas-Gutierrez
-
Karin Tarte
-
Cédric Portugues
-
Emmanuel Itti
-
Xavier Palard-Novello
-
Paul Blanc-Durand
-
Yassine Al Tabaa
-
Clément Bailly
-
Camille Laurent
-
François Lemonnier
-
September 22, 2026
